Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 2, 2010, Pages 849-854

  Gupta, Shuchi ^a   Poeppelman, Lee ^a   Hinman, Channing L ^a   Bretz, James ^a   Hudson, Richard A ^a,b   Tillekeratne, L M Viranga ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Apoptosis; Styryllactone; Synergism; TRAIL

Indexed keywords

GONIOTHALENOL; LACTONE DERIVATIVE; STYRYLLACTONE DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; STEREOCHEMISTRY; STEREOISOMERISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LACTONES; MOLECULAR CONFORMATION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED;

EID: 76449113028     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.11.045     Document Type: Article

References (22)

1. Blazquez M.A., Bermejo A., Zafra-Polo M.C., and Cortes D. Phytochem. Anal. 10 (1999) 161
2. Fang X., Anderson J.E., Qui X., Kozlowski J.F., Chang C., and McLaughlin J.L. Tetrahedron 49 (1993) 1563
3. Bermejo A., Blazquez M.A., Rao K.S., and Cortes D. Phytochem. Anal. 10 (1999) 127
4. Bermejo A., Lora M.J., Blazquez M.A., Rao K.S., Cortes D., and Zafra-Polo M.C. Nat. Prod. Lett. 7 (1995) 117
5. Zhao G., Wu B., Wu X.Y., and Zhang Y.Z. Mini-Rev. Org. Chem. 2 (2005) 333
6. Mukai C., Hiraj S., and Hanaoka M. J. Org. Chem. 62 (1997)
7. Tsubuki M., Kanai K., Nagase H., and Honda T. Tetrahedron 55 (1999) 2493
8. Yadav J.S., Rajaiah G., and Raju A.K. Tetrahedron Lett. 44 (2003) 5831
9. Yadav J.S., Raju A.K., Rao P.P., and Rajaiah G. Tetrahedron: Asymmetry 16 (2005) 3283 6619
10. Prasad K.R., and Gholap S.L. J. Org. Chem. 73 (2008) 2
11. Favre A., Carreaux F., Deligny M., and Carboni B. Eur. J. Org. Chem. (2008) 4900
12. Enders D., and Barbion J. Chem. Eur. J. 14 (2008) 2842
13. El-Zayat A.A., Ferrigni N.R., McCloud T.G., McKenzie A.T., Byrn S.R., Cassady J.M., Chang C.J., and McLaughlin J.L. Tetrahedron Lett. 26 (1985) 955
14. Fang X.P., Anderson J.E., Chang C.J., and McLaughlin J.L. Tetrahedron 47 (1991) 9751
15. Mereyala H.B., and Joe M. Curr. Med. Chem.: Anti-Cancer Agents 1 (2001) 293
16. Kim Y., and Seol D.-W. Mol. Cells 15 (2003) 283
17. Zoli W., Ricotti L., Tesei A., Barzanti F., and Amadori D. Crit. Rev. Oncol.: Hematol. 37 (2001) 69
18. Gupta S., Rajagopalan M., Alhamadsheh M., Tillekeratne L.M.V., and Hudson R.A. Synthesis (2007) 3512
19. LeBlanc H.N., and Ashkenazi A. Cell Death Differ. 10 (2003) 66
20. Inayat-Hussain S.H., Osman A.B., Din L.B., and Taniguchi N. Toxicol. Lett. 13 (2002) 153
21. Bermejo A., Léonce S., Cabeo N., Andreu I., Caignard D.H., Atassi G., and Cortes D. J. Nat. Prod. 62 (1999) 1106
22. Smith C.A., and Hinman C.L. J. Biochem. Mol. Toxicol. 18 (2004) 204